No black box warning on record for Eptifibatide

As of the latest FDA labeling reviewed, Eptifibatide (EPTIFIBATIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Eptifibatide medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Eptifibatide can cause serious bleeding. If bleeding cannot be controlled, discontinue eptifibatide immediately. Minimize vascular and other traumas. If heparin is given concomitantly, monitor aPTT or ACT. (5.1) Thrombocytopenia: Discontinue eptifibatide and heparin. Monitor and treat condition appropriately. (5.2) 5.1 Bleeding Bleeding is the most common complication en

No black box warning on record for Eptifibatide

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Eptifibatide can cause serious bleeding. If bleeding cannot be controlled, discontinue eptifibatide immediately. Minimize vascular and other traumas. If heparin is given concomitantly, monitor aPTT or ACT. (5.1) Thrombocytopenia: Discontinue eptifibatide and heparin. Monitor and treat condition appropriately. (5.2) 5.1 Bleeding Bleeding is the most common complication en

Eptifibatide Black Box Warning

No black box warning on record for Eptifibatide

Other warnings & precautions

Eptifibatide Black Box Warning

No black box warning on record for Eptifibatide

Other warnings & precautions